Literature DB >> 33577699

Long-term Outcomes and Complications of the New Carlevale Sutureless Scleral Fixation Posterior Chamber IOL.

Agostino S Vaiano, Kenneth J Hoffer, Antonio Greco, Andrea Greco, Giovanni D'Amico, Valerio Pasqualitto, Carlo Carlevale, Giacomo Savini.   

Abstract

PURPOSE: To evaluate the visual outcomes and possible complications of a new foldable sutureless scleral fixation intraocular lens (SSF-IOL), the Carlevale IOL (Soleko).
METHODS: The SSF-IOL, which has two T-shaped self-blocking plugs on each haptic, was inserted into the posterior chamber. Both haptics was grabbed through two sclerotomies and the two short arms were blocked under the scleral flap, without any suture. A complete clinical evaluation was done preoperatively and at 3, 6, and 12 months postoperatively.
RESULTS: A total of 54 eyes of 50 consecutive patients were retrospectively analyzed. The mean corrected distance visual acuity was 0.93 ± 0.61 logMAR preoperatively and improved to 0.42 ± 0.34 logMAR at 3 months, 0.42 ± 0.37 logMAR at 6 months, and 0.38 ± 0.38 logMAR at 12 months postoperatively (all P < .0001). The mean corneal endothelial cell density decreased from 1,725.37 ± 528.06 to 1,612.81 ± 522.91 cells/mm2 at 12 months postoperatively (P < .0001). The mean IOL tilt value was 3.1 ± 1.1° at 12 months postoperatively. The authors observed 6 cases (11.1%) of intraoperative rupture of the IOL haptics, 4 cases (7.4%) of early hyphema, 4 cases (7.4%) of macular cystoid edema, 2 cases (3.7%) of haptic exposure under the conjunctiva, and 1 (1.8%) late retinal detachment.
CONCLUSIONS: This newly introduced surgical technique provided promising results regarding efficacy and safety. Complications occurred in a few cases and were successfully managed. The Carlevale IOL seems to be a surgical solution combining the advantages of an easy and minimally invasive implantation with a good functional recovery with minimal complications. [J Refract Surg. 2021;37(2):126-132.]. Copyright 2021, SLACK Incorporated.

Entities:  

Year:  2021        PMID: 33577699     DOI: 10.3928/1081597X-20201207-02

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Clinical outcome and endothelial loss following prepupillary and retropupillary implantation of iris claw intraocular lenses.

Authors:  Ebubekir Durmus; Fehim Esen; Melda Yenerel; Huseyin Sanisoglu; Halit Oguz
Journal:  Int Ophthalmol       Date:  2021-07-29       Impact factor: 2.031

2.  Secondary Sutureless Posterior Chamber Lens Implantation with Two Specifically Designed IOLs: Iris Claw Lens versus Sutureless Trans-Scleral Plugs Fixated Lens.

Authors:  Daniel Seknazi; Donato Colantuono; Rachid Tahiri; Francesca Amoroso; Alexandra Miere; Eric H Souied
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.